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Regulation of metabolic pathways in the immune
system provides a mechanism to actively control
cellular function, growth, proliferation, and survival.
Here, we report that miR-181 is a nonredundant
determinant of cellular metabolism and is essential
for supporting the biosynthetic demands of early
NKT cell development. As a result, miR-181-deficient
mice showed a complete absence of mature NKT
cells in the thymus and periphery. Mechanistically,
miR-181 modulated expression of the phosphatase
PTEN to control PI3K signaling, which was a primary
stimulus for anabolic metabolism in immune cells.
ThusmiR-181-deficientmice also showed severe de-
fects in lymphoid development and T cell homeosta-
sis associated with impaired PI3K signaling. These
results uncover miR-181 as essential for NKT cell
development and establish this family of miRNAs
as central regulators of PI3K signaling and global
metabolic fitness during development and homeo-
stasis.
INTRODUCTION
Until recently, metabolism was considered a "house-keeping"
utility that merely supported cellular processes. However, it is
now clear that the regulation of metabolic pathways in the
immune system provides a mechanism to actively control
cellular function, growth, proliferation, and survival. Signaling
through the phosphatidylinositol 3-kinase (PI3K) pathway pro-
vides a potent stimulus for anabolic metabolism during lymphoid
development and immune responses, but it must be tightly
controlled if cancer and autoimmunity are to be avoided (Alimonti
et al., 2010; Pal et al., 2012). The phosphatase PTEN is the prin-
cipal and nonredundant negative regulator of the PI3K pathway;984 Immunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc.as a result, organisms are exquisitely sensitive to PTEN expres-
sion (Alimonti et al., 2010). Robust mechanisms must therefore
exist to precisely coordinate PTEN expression with the transcrip-
tional programs that promote lineage specification and differen-
tiation in the immune system, and regulation by miRNAs
provides one exciting possibility. We therefore hypothesized
that miRNA families that are specialized in the coordination of
anabolic metabolism during lymphoid development and homeo-
stasis in vivo are likely to have evolved. Previous work has
revealed miRNAs with the capacity to regulate the PI3K-PTEN
axis; however, the lack of in vivo developmental phenotypes
associated with impaired anabolic metabolism in miRNA-defi-
cient mice indicates that miRNAs responsible for cellular meta-
bolic regulation have yet to be identified (Ebert and Sharp,
2012; Huse et al., 2009; Inui et al., 2010; Ma et al., 2011; Mendell
and Olson, 2012; Olive et al., 2009; Park et al., 2010; Patrick
et al., 2010; Small et al., 2010; Ventura et al., 2008).
The development of T cells and Natural Killer T (NKT) cells in
the thymus is a life-long process that requires high proliferation
rates and therefore elevated biosynthetic demands; PI3K
signaling is a critical anabolic determinant required for the sup-
port of these proliferative developmental stages (Fayard et al.,
2010; Finlay et al., 2010). Although much is known about the
transcriptional programs and signaling pathways that regulate
these essential metabolic adaptations during NKT cell and
T cell development, the role of noncoding RNAs in controlling
such processes is mostly unknown. Interestingly, thymic abla-
tion of the miRNA-processing enzyme Dicer causes defects in
thymocyte development as well as a complete loss of NKT cells
in the thymus and periphery; however, the identity of the individ-
ual microRNAs and the mechanism through which they regulate
NKT development remain largely undetermined (Cobb et al.,
2005; Fedeli et al., 2009; Zheng et al., 2012).
We revealed that miR-181 was an essential regulator of PI3K
signaling strength, through PTEN modulation, and therefore
was a critical determinant of cellular metabolic adaptations
required for the support of high proliferation rates during devel-
opment. Accordingly, miR-181-deficient mice showed a com-
plete absence of mature NKT cells in the thymus and periphery.
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several hematopoietic and nonhematopoietic defects associ-
ated with reduced metabolic fitness driven by impaired PI3K
signaling. Altogether, these results provide important insights
into the physiological function of this miRNA family; moreover,
it places miR-181 as a central in vivo regulator of cellular meta-
bolic fitness during development and homeostasis.
RESULTS
miR-181 Determines Organism Size
The miR-181 family is composed of six mature miRNAs—miR-
181a1, miR-181a2, miR-181b1, miR-181b2, miR-181c, and
miR-181d—which are encoded in three independent paralog
precursor transcripts on three separate chromosomes (Ji et al.,
2009). The mature forms of miR-181a1 and miR-181a2, as well
as those of miR-181b1 and miR-181b2, are identical in
sequence. Furthermore, all family members contain the same
50 "seed’’ sequence, suggesting a significant degree of func-
tional redundancy (Ji et al., 2009). To test the function of the
miR-181 family in vivo, we generated mice in which each of the
three miR-181 gene clusters was flanked by loxP sites so that
tissue-specific deletion was possible (Figures S1A–S1C, in the
Supplemental Information available with this article online).
Mice deficient for the microRNA clusters miR-181a1b1 (contain-
ing Mir181a-1 and Mir181b-1), miR-181a2b2 (containing
Mir181a-2 and Mir181b-2), and miR-181cd (containing Mir181c
and Mir181d) were obtained in predicted Mendelian ratios, and
none of these lines displayed any obvious gross phenotypic
abnormalities in terms of growth, development, or survival. In
contrast, mice carrying compound deletions of the different
miR-181 clusters demonstrated reduced survival and decreased
body weight when they were compared to littermates, suggest-
ing that this miRNA family regulates an essential pathway in vivo
(Figures 1A and S1D and data not shown). Indeed, mice deficient
for all three miR-181 clusters have yet to be obtained, providing
evidence that complete deficiency of the miR-181 family might
not be compatible with life.
miR-181 Regulates PI3K Signaling by Modulating PTEN
Expression
NKT cells and conventional T cells develop from a common pro-
genitor cell in the thymus in an ordered multi-step program.
Because miR-181a and miR-181b are highly expressed in the
thymus from the miR-181a1b1 cluster locus, we focused on
the characterization of the miR-181a1b1-deficient line (Figures
S1A and S1E). As an initial approach, we performed an unbiased
RNA-Seq analysis of sorted CD4+CD8+ double-positive (DP)
thymocytes. DP thymocytes were chosen because they repre-
sent the point of divergence between NKT cell and conventional
T cell development and because Dicer-deficient mice have a
complete block during the very early stages of NKT cell develop-
ment (Fedeli et al., 2009). We sequenced triplicate RNAs on an
Illumina HiSeq 2000 and mapped R 64.0 3 106 paired-end
reads of 76 bp to the mouse genome (mm9) for each replicate
by using Tophat (Trapnell et al., 2009). Mouse UCSC transcripts
were quantified, and differentially expressed genes were identi-
fied with Cuffdiff2 (data not shown). Analysis of replicate FPKM
(fragments per kilobase of transcript model, per million frag-ments mapped) distributions, appropriate hierarchical clustering
of biological replicates, and a low squared coefficient of variation
between replicate expression values confirmed that the samples
were of good quality (Figures S1F–S1H). Differential gene anal-
ysis revealed 2,612 differentially expressed genes between
wild-type (WT) and miR-181a1b1-deficient DP thymocytes;
more than 80% of these genes were downregulated in the
miR-181a1b1-deficient cells (Figure 1B). The observation that
deletion of a single miR-181 cluster was sufficient to cause
deregulation of a vast number of genes suggests that this miRNA
family controls a central regulatory pathway. To confirm a global
derepression of miR-181 targets inmiR-181a1b1-deficient mice,
we prepared a FPKM-rank-ordered (WT/miR-181a1b1-deficient)
list of genes and used it as input for a preranked gene-set enrich-
ment analysis (GSEA) (Subramanian et al., 2005) against the
MSigDB microRNA target-gene set (C3 miRNA v.3.0; MSigDB).
The greatest significant association (p < 0.001; Kolmogorov-
Smirnov test) was observed for genes in the miR-181 target-
gene set and confirms a transcriptome-wide increase in
predicted miR-181 target genes in miR-181a1b1-deficient DP
thymocytes (Figure 1C). Of the 146 predicted miR-181 targets
that were identified as significantly upregulated in miR-
181a1b1-deficient DP thymocytes, we were particularly
intrigued by the gene Pten (phosphatase and tensin homolog),
the principal negative regulator of the PI3K pathway. Pten was
an attractive target because it is a nonredundant regulator of a
central pathway common in all cells; moreover, small changes
in Pten transcript levels usually have large phenotypic conse-
quences (Alimonti et al., 2010; Carracedo et al., 2011; Garcia-
Cao et al., 2012; Ortega-Molina et al., 2012). RNA-Seq analysis
showed that Pten mRNA was approximately 65% higher in
miR-181a1b1-deficient DP thymocytes than in WT cells (Fig-
ure 1D). Upregulation of PTEN in miR-181a1b1-deficient thymo-
cytes was confirmed by immunoblot analysis (Figures 1E and 1F,
and S1I). In support of PtenmRNA as a potential miR-181 target,
there are four predicted (by the Dianalab algorithm) miR-181
sites in the 30 UTR of Pten (Figure S1J).
We predicted that increased PTEN expression would result in
reduced PI3K signaling in DP thymocytes. Thymocyte develop-
ment requires PI3K activation through CXCR4, and ex vivo
stimulation of thymocytes with the CXCR4 ligand CXCL12
represents a physiologically relevant system for interrogation
of PI3K signaling ex vivo (Janas et al., 2010). Using intracellular
flow cytometry, we measured the amount of AKT phosphoryla-
tion on serine 473 (p-AKT) in freshly isolated thymocytes after
in vitro stimulation with CXCL12 (Figure 1G). Although DP
thymocytes from miR-181a1b1-deficient mice and WT cells
contained similar amounts of p-AKT 1 min after stimulation,
loss of p-AKT occurred at a faster rate in miR-181a1b1-deficient
cells, suggesting that the increased PTEN expression attenu-
ated PI3K signaling downstream of CXCR4. Importantly,
Cxcr4 transcription (as determined by RNA-Seq) was not signif-
icantly changed in the absence of miR-181a1b1 (data not
shown). It has previously been suggested that miR-181 acts
as an intrinsic modulator of T cell receptor (TCR) signaling
strength through the downregulation of different phosphatases
that dampen ERK signaling (Ebert et al., 2009; Li et al., 2007).
Moreover, it has been suggested that miR-181 regulates
NOTCH1 signaling indirectly through modulation of negativeImmunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc. 985
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Figure 1. miR-181 Regulates Survival, Organism Size, and PTEN Expression in Thymocytes
(A) Survival rates of mice with compound deletions of the miR-181a1b1 (a1b1WT, a1b1HET, or a1b1KO) and the miR-181a2b2 (a2b2WT, a2b2HET, or a2b2KO)
clusters (n = 245).
(B) (Panel 1) Scatter plot of gene-level expression estimates from RNA-Seq of WT (a1b1WT) versus miR-181a1b1-deficient (a1b1KO) DP thymocytes. (Panel 2)
Volcano plot highlighting log2 ratios (a1b1WT/a1b1KO) of gene-expression estimates versus differential-expression significance values.
(C) GSEA plot demonstrating enrichment of miR-181 target genes in miR-181a1b1-deficient DP thymocytes. The x axis represents the rank ordering
(a1b1WT/a1b1KO) of all genes. A running GSEA enrichment score for miR-181 target genes (red) is plotted along the rank order. miR-181 target genes are
individually identified with a black tick mark at their rank positions. A density plot of miR-181 target genes is presented; darker blue indicates a greater number of
target genes.
(D) Relative amounts of Pten expression from RNA-Seq data in DP thymocytes from WT and miR-181a1b1-deficient mice.
(E) Protein-blot analysis of PTEN in total thymocytes from WT and miR-181a1b1-deficient mice. Each lane represents thymocytes from a single mouse.
(F) Protein-blot analysis of PTEN in sorted DN1-3 and DN4 thymocytes fromWT andmiR-181a1b1-deficient mice. Each lane represents thymocytes from a single
mouse.
(G) Intracellular stain of phospho-AKT (Ser473) after stimulation with CXCL12 for the indicated times. Representative of five independent experiments.
(H) Abbreviated heatmap of FOXO target-gene log2 n-fold-change values (fill color). Those genes identified as significantly differentially expressed are indicated
with a black border.
(I and J) Cell-surface expression of CD62L on thymocytes from WT and miR-181a1b1-deficient mice. (n = 5, data are representative of four independent
experiments). All error bars indicate mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S1.
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found no evidence to support this (Figures S2A–S2D). More-
over, we did not observe any gross defects in TCR signaling
strength (Figures S2B and S2E–S2H). Downstream of PI3K,986 Immunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc.activated AKT phosphorylates and inhibits FOXO proteins;
FOXO proteins are transcription factors, which can either acti-
vate or repress target genes to regulate numerous cellular
responses. Analysis of changes in gene expression of FOXO
Immunity
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ity (Carracedo et al., 2011). Examination of the RNA-Seq data
revealed that a significant number of predicted FOXO target
genes (36/369; p = 9.21 3 104; hypergeometric test) were
differentially regulated in miR-181a1b1-deficient DP thymo-
cytes (Figure 1H). Moreover, genes that are known to be acti-
vated by FOXO proteins were significantly upregulated in miR-
181a1b1-deficient DP thymocytes, whereas FOXO-repressed
genes were significantly upregulated in WT DP thymocytes. Of
interest, we found an upregulation of the confirmed FOXO target
genes Ctla4, Cd28, and Sell (encoding CD62L) in miR-181a1b1-
deficient DP thymocytes. We further validated these RNA-Seq
findings by confirming that surface expression of CD62L was
significantly elevated in DN4 (double-negative 4), DP, and
CD4 SP (single-positive) thymocytes of miR-181a1b1-deficient
mice (Figures 1I and 1J). Thus, miR-181a1b1 ablation increased
PTEN activity, resulting in decreased signaling downstream
of PI3K.
miR-181a1b1 Deficiency Alters Cellular Metabolism
PI3K-AKT signaling leads to increased MYC activity and activa-
tion of the mTORC1 complex, which together are responsible for
driving multiple anabolic processes, including the transcriptional
upregulation of metabolic enzymes required for meeting the en-
ergetic and biosynthetic demands of growth and proliferation.
We therefore examined the RNA-Seq data to determine whether
there was evidence of reduced signaling downstream of PI3K in
the form of a disrupted metabolic gene signature in miR-
181a1b1-deficient DP thymocytes. This analysis revealed that
key components of the glycolytic pathway, pentose phosphate
pathway, and nucleotide biosynthetic pathways were signifi-
cantly downregulated in miR-181a1b1-deficient DP thymocytes
(Figures 2A and 2B). In contrast, expression of the genes
involved in glutaminolysis and b-oxidation were minimally dysre-
gulated in miR-181a1b1-deficient thymocytes. Expression of
genes involved in cell-cycle regulation were also minimally
changed in miR-181a1b1-deficient thymocytes, highlighting
the specificity of the metabolic reprogramming gene signature
(Figure 2B).
The pyruvate kinase isoform PKM2 promotes both aerobic
glycolysis and anabolic metabolism (Christofk et al., 2008). Inter-
estingly, as compared to WT DP thymocytes, miR-181a1b1-
deficient DP thymocytes had significantly reduced amounts of
Pkm2 mRNA, and such a reduction could potentially impair
anabolic metabolism and the ability of miR-181a1b1-deficient
cells to proliferate (Figure 2C).
GLUT1 (also known as SLC2A1) is the primary glucose trans-
porter expressed on developing thymocytes and is required dur-
ing the DN-to-DP transition so that the metabolic requirements
of proliferation can be met (Juntilla et al., 2007). PI3K-AKT
signaling and MYC positively regulate transcription of Slc2a1
(Barthel et al., 1999; Osthus et al., 2000). PI3K signaling also
initiates trafficking of GLUT1 to the plasma membrane (Wieman
et al., 2007). Glut1 mRNA was significantly downregulated in
miR-181a1b1-deficient DP thymocytes (Figure 2A). As a
consequence, thymocytes displayed a significantly reduced
capacity for glucose uptake, as revealed by decreased acquisi-
tion of the fluorescent deoxyglucose analog 2-NBDG (Fig-
ure 2D). PI3K signaling is also required for expression of thenutrient transporters CD98 (amino acid transporter, SLC3A2)
and CD71 (transferrin receptor) (Kelly et al., 2007). Cell-surface
expression of both CD98 and CD71 was significantly reduced
in the absence of the miR-181a1b1 cluster on multiple thymo-
cyte populations, as determined by flow cytometry (Figures 2E,
2F, and S2I).
Activation of mTORC1 by AKT drives increased translation
through multiple mechanisms, including activation of ribosomal
proteins and increased transcription of ribosomal RNA and
genes encoding ribosomal proteins (Hay and Sonenberg,
2004). In agreement with this, analysis of the RNA-Seq data
revealed a significant reduction in the expression of ribosomal
proteins in miR-181a1b1-deficient DP thymocytes (Figure 2A).
Altogether, these data reveal that deletion of the single miR-
181a1b1 cluster is sufficient to induce a major metabolic reprog-
ramming at the genetic level.
To directly assess whether the altered metabolic gene signa-
ture of miR-181a1b1-deficient thymocytes translated to altered
metabolism, wemeasured rates of aerobic glycolysis and oxida-
tive phosphorylation. The extracellular acidification rate (ECAR)
is used as a measure of lactate produced during glycolysis. Thy-
mocytes from miR-181a1b1-deficient mice displayed a 50%
reduction in ECAR, indicating that glycolysis is significantly
decreased (Figure 2G). In contrast, oxygen consumption rates
(OCRs), which report levels of oxidative phosphorylation, were
not significantly altered betweenWT andmiR-181a1b1-deficient
thymocytes (Figure 2H). Flow-cytometric assessment of mito-
chondrial mass and production of mitochondrial reactive oxygen
species (ROSs) also revealed no significant differences between
WT and miR-181a1b1-deficient thymocytes (Figures 2I and 2J).
The suboptimal glucose uptake and reduced glycolytic rates
indicate that miR-181a1b1-deficient thymocytes have reduced
metabolic fitness, which would result in an impaired capacity
for cell growth and proliferation.
miR-181a1b1 Deficiency Perturbs T Cell Development
The results presented above show that deletion of the miR-
181a1b1 cluster causes a significant metabolic reprogramming
in DP thymocytes. Because DP thymocytes represent the point
of divergence for the development of NKT cells and conventional
T cells (which are both PI3K dependant), we predicted that the
generation of both lineages would be severely impacted in
miR-181a1b1-deficient mice.
Mice with targeted deletion of individual components of the
PI3K pathway display characteristic developmental phenotypes
in the thymus (Fayard et al., 2007; Finlay et al., 2010; Hinton et al.,
2004; Ji et al., 2007; Sasaki et al., 2000; Swat et al., 2006; Webb
et al., 2005). These include thymic hypocellularity, a decreased
percentage of DN1 thymocytes, and maintained expression of
CD25 on thymocytes from the DN3 to DP stages. Interestingly,
miR-181a1b1-deficient mice displayed evidence for each of
these developmental defects, reflecting reduced capacity for
PI3K signaling as a consequence of PTEN overexpression (Fig-
ures 3A, 3B, and S3A–S3D).
Metabolic alterations associated with PI3K signaling defi-
ciency drives thymic hypocellularity by altering the balance of
proliferation and apoptosis in the thymus (Fayard et al., 2007;
Finlay et al., 2010; Hinton et al., 2004; Sasaki et al., 2000; Swat
et al., 2006; Webb et al., 2005). Therefore, to assess theImmunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc. 987
0
200
250
300
350
400
2-
N
BD
G
-M
FI
G
lu
co
se
 u
pt
ak
e
***
0
8000
8000
9000
10000
11000
12000
M
ito
ch
on
dr
ia
lm
as
s
(M
FI
)
n.s
A B
C D
0
100
200
300
EC
AR
(m
pH
/m
in
)
**
0
100
200
300
400
500
O
C
R
(p
M
ol
es
/m
in
)
n.sHG
0
150
170
230
290
350
C
D
98
M
FI
 (D
P 
th
ym
oc
yt
es
)
 *
0
16
20
24
28
32
C
D
71
M
FI
 (D
P 
th
ym
oc
yt
es
)
***E F
I
Rps23
Fau
Rpl5
Rps7
Rpl36al
Rpl38
Rpl23a
Rpl27
Rpl10a
Rpl17
Rps10
Rpl36a
Rpl13
Rps3
Rpl15
Rpl7a
Rpl26
Rpl32
Rps16
Rpl34
Rpl6
Rpl18
Rps18
Rpl18a
Rpl19
Rpl12
Rpl37a
Rpl28
Rps19
Rpl29
Rps28
Rpl11
Rpl14
Rps17
Rpl13a
Rps20
Rpl3
Rps5
Rpsa
Rps9
Rpl8
Rps26
Rps15
Uba52
Rpl35
Rplp2
Rpl41
Rplp1
Rpl3l
Rpl36
Rps21
Rpl37
R
ib
os
om
al
 G
en
es
G
ly
co
ly
si
s 
G
en
es
Aldob
Eno3
Pfkp
Hk1
Slc2a3
Pgk1
Ldha
Pgam1
Ldhd
Hk2
Pfkm
Tpi1
Eno1
Gpi1
Gapdh
Pgam2
Pfkl
Pkm2
Ldhb
Slc2a1
Aldoc
Aldoa
Myc
Slc2a4
Eno2
Slc2a8
P
ur
in
e 
B
io
sy
nt
he
si
s 
G
en
es
Ak1
Ak3
Adss
Gmps
Ppat
Paics
Rrm1
Nme7
Atic
Pfas
Rrm2
Adsl
Gart
Ak2
Impdh2
Guk1
Impdh1
Adssl1
Nme1
Nme3
Nme6
Nme4
Nme2
Nme5
Nme7
Umps
Ctps
Cad
Dhodh
Nme1
Nme3
Nme6
Nme4
Nme2
P
yr
im
id
in
e 
B
io
sy
nt
he
si
s 
G
en
es
Rpe
Rpia
G6pdx
Pgd
Pgls
Taldo1
Tkt
P
en
to
se
 P
ho
sp
ha
te
 P
at
hw
ay
 G
en
es
Echs1
Cpt1c
Hadhb
Cpt1b
Acad9
Hadha
Acat1
Acat2
Cpt2
Cpt1a
B-
O
xi
da
tio
n 
of
 F
at
ty
 A
ci
ds
 G
en
es
G
lu
ta
m
in
ol
ys
is
 P
at
hw
ay
 G
en
es
Gls1
Gls2
Slc38a1
Glud1
Gpt2
Got2
Slc3a2
Got1
Slc7a5
Gpt1
Significant FDR 5%
no yes
log2 WT / KO
−2 −1 0 1 2
0
2000
2000
3000
4000
5000
M
ito
so
x
(M
FI
)
M
ito
ch
on
dr
ia
l O
2-
n.sJ
0
50
100
Pk
m
2 
(F
PK
M)
***
Pathway
p=
9.2
1•1
0−
04
p=
1.6
9•1
0−
04
p=
2.0
2•1
0−
03
p=
4.7
0•1
0−
04
p=
1.0
0
p=
1.0
0
p=1.91•10−13
p=
3.6
2•1
0−
05
p=
1.7
8•1
0−
03
p=
1.2
4•1
0−
01
p=
1.7
0•1
0−
01
p=
4.3
9•1
0−
01
0
5
10
R
ibosom
al Proteins
Purine Biosynthesis 
Pentose Phosphate 
G
lycolysis 
Foxo Targets
Pyrim
idine Biosynthesis 
m
Tor Signaling
 G
1/S Checkpoint regulation
Cyclins and cell cycle regulation
G
2/M
 Checkpoint regulation
G
lutam
inolysis 
B−O
xidation of Fatty Acids 
−
lo
g1
0(p
.va
lue
)
a1b1WT a1b1KO a1b1WT a1b1KO a1b1WT a1b1KO a1b1WT a1b1KO
a1b1WT a1b1KO a1b1WT a1b1KO a1b1WT a1b1KO a1b1WT a1b1KO
Figure 2. Thymocytes Deficient in miR-181a1b1 Display an Altered Metabolic Gene Signature and Reduced Rates of Glycolysis
(A) Heatmap of log2 n-fold-change values for genes in specific metabolic pathways. Those genes identified as significantly differentially expressed are indicated
with a black border.
(B) Hypergeometric p-values for PI3K-associated metabolic pathways with a significant number of differentially expressed genes, analysis of various cell cycle
pathways is also included.
(C) Relative amount of Pkm2 mRNA from RNA-Seq data in DP thymocytes from WT and miR-181a1b1-deficient mice.
(D) Flow-cytometry analysis of 2-NBDG uptake by WT and miR-181a1b1-deficient DP thymocytes. (n = 5–6; data are representative of two independent
experiments).
(E) Cell-surface expression of CD98 onDP thymocytes fromWT andmiR-181a1b1-deficientmice, as revealed by flow cytometry. (n = 5–6; data are representative
of two independent experiments).
(F) Cell-surface expression of CD71 on DP thymocytes fromWT andmiR-181a1b1-deficient mice, as revealed by flow cytometry. (n = 5–6; data is representative
of two independent experiments).
(legend continued on next page)
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miR-181 Is an Essential Metabolic Rheostat In Vivoproliferation of thymocytes in vivo, we injected WT and
miR-181a1b1-deficient mice with a single dose of BrdU
and harvested thymocytes 24 hr later. The absolute number
and percentage of BrdU+ DP thymocytes were reduced in
miR-181a1b1-deficient mice, revealing that proliferation during
this developmental stage is indeed significantly impaired (Fig-
ure 3C). When cultured ex vivo, DP cells rapidly underwent
apoptosis in the absence of survival signals. Thymocytes from
miR-181a1b1-deficient mice showed increased apoptosis in
culture over time, as revealed by flow-cytometric quantification
of annexin V staining (Figure 3D). Dexamethasone, a glucocorti-
coid steroid, induces thymocyte apoptosis in vitro and in vivo
and is thought to mimic a process termed ‘‘death by neglect’’
(Wang et al., 1999; Zilberman et al., 2004). miR-181a1b1-defi-
cient DP thymocytes cultured in the presence of increasing con-
centrations of dexamethasone were more prone to apoptosis
than were WT cells (Figure S3E). To test survival in vivo, we in-
jected WT and miR-181a1b1-deficient mice with a single dose
of dexamethasone to induce thymocyte apoptosis. In agreement
with in vitro observations, miR-181a1b1-deficient thymocytes
were more susceptible to dexamethasone-induced apoptosis
in vivo (Figure 3E).
Mutations that reduce thymocyte survival manifest as a
decrease in the frequency of rearrangement of TCR distal Ja
gene segments (D’Cruz et al., 2010; Guo et al., 2002). To obtain
a functional readout of thymocyte survival in vivo, we assessed
usage of each Va and Ja gene segment in sorted CD4 SP thymo-
cytes by global sequencing of Tcra transcripts (Figures 3F and
S3F). From this analysis, it was evident that inmiR-181a1b1-defi-
cientmice Jageneusagewas significantly biased in favor of prox-
imal Jagenesegments versusmoredistal Jagenesegments, indi-
cating thatmiR-181a1b1-deficient thymocytes have adecreased
lifespan in vivo. Thus, in linewitha reducedPI3K-drivenmetabolic
fitness, miR-181a1b1-deficient thymocytes show decreased
proliferative capacity and decreased survival in vivo.
Dysregulation of PTEN Levels inmiR-181a1b1-Deficient
Mice Blocks NKT Cell Development
NKT cells are a highly prevalent population of innate-like T cells
that have been shown to be important in clearing tumors, pre-
venting autoimmunity, and fighting infections. Most NKT cells
express the canonical TCRa chain, composed of a chain variable
region 14 and a chain joining region 18 (Va14-Ja18), together with
the TCR Vb8, Vb7, or Vb2 chain, which as a heterodimeric com-
plex confers specificity to glycolipid ligands. Upon analysis of
Tcra gene-segment usage in CD4 SP thymocytes, we noted
a significant underrepresentation of the Va14–Ja18 NKT TCR
(Figure 4A) (designated Trav11.02–Traj18.01 per updated
nomenclature).
Flow cytometry, using CD1d tetramers loaded with alpha-
galactosylceramide (aGalCer), revealed an almost complete(G and H) Metabolic analysis using the Seahorse XF96 Extracellular Flux Analyzer.
(OCRs) of thymocytes from WT and miR-181a1b1-deficient mice. Each point re
experiments).
(I) Flow-cytometry assessment of mitochondrial mass (with mitotracker green) and
fromWT andmiR-181a1b1-deficient mice. Each point represents a singlemouse.
indicate mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S2.absence of NKT cells in the thymus, spleen, and liver of miR-
181a1b1-deficient mice (Figure 4B). Because mice in which we
had conditionally deleted the miR-181a1b1 cluster by using
Cd4-Cre also lacked NKT cells, we reasoned that the defect in
NKT development most likely occurred during or after the DP
thymocyte stage (Figure 4C). NKT deficiency was specific to
mice having lost the miR-181a1b1 cluster; miR-181a2b2- and
miR-181cd-deficient mice did not display reductions in NKT
cell numbers, reflecting the expression profiles of each of the
miR-181 members (Figures S4A and S4B)(Kuchen et al., 2010).
NKT cells are selected by glycolipids presented in the context
of CD1d displayed on the surface of DP cortical thymocytes, and
defects in CD1d expression preclude NKT development. How-
ever, we found no evidence for reduced CD1d expression or
for a processing or presentation defect of miR-181a1b1-defi-
cient cortical thymocytes, indicating that the deficiency in NKT
cells was cell intrinsic (Figures 5A–5C and S4C). We have also
excluded defects in three molecules (RORgt, Bcl-xL, and BIM)
that are critical for two survival axes and that have previously
been shown to regulate NKT cell development (Figures 5D, 5E,
and S5A–S5D). Moreover, the fact that the deficit in NKT cell
development prevails in NKT TCR transgenic mice suggests
that defects that occur in Tcra rearrangement as a result of
reduced thymocyte survival are not the singular cause of the
NKT cell developmental block in miR-181a1b1-deficient mice
(Figures 5F and S5E).
Genetic Reduction of PTEN Levels Restores NKT Cell
Development in miR-181a1b1-Deficient Mice
NKT development can be divided into four (0–3) discrete stages
based on the expression of the cell-surface markers NK1.1,
CD44, and CD24. Expression of miR-181a and miR-181b was
highest in DP thymocytes and decreased as NKT development
progressed to stage 3 (Figure 6A). In order to determine at which
stage NKT development is blocked in miR-181a1b1-deficient
mice, we performed tetramer enrichment of NKT cells pooled
from the thymus of 4–5 mice by using aGalCer-loaded CD1d
tetramers and then flow cytometry (Figures 6B and 6C). Immedi-
ately after positive selection, stage 0 developmental intermedi-
aries, which are present in very low numbers, undergo amassive
proliferative expansion in a PI3K-dependent manner (Finlay
et al., 2010). Similar to what has been shown in PDK1- and
Dicer-deficient animals, deletion of the miR-181a1b1 cluster
resulted in a developmental block during the metabolically
demanding transition from stage 0 to 1, whereas later stages
showed no obvious defects (Figures 6B and 6C). Because
of the similarity between miR-181b1-deficient mice and PDK1-
deficient animals, we hypothesized that proliferation of early-
stage NKT cells would also be defective in the miR-181a1b1-
deficient mice. Indeed, BrdU-incorporation experiments in
Tg-Va14-Ja18 and Tg-Va14-Ja18 miR-181a1b1-deficient mice(G) Extracellular acidification rates (ECARs) and (H) oxygen consumption rates
presents a single mouse. (n = 4; data are representative of three independent
(J) mitochondrial reactive oxygen species (with mitosox red) in DP thymocytes
(n = 5–6; data are representative of two independent experiments). All error bars
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Figure 3. Deletion of miR-181a1b1 Perturbs Thymocyte Development
(A) Absolute thymocyte numbers and representative flow-cytometry plots showing thymocyte populations from age-matched WT and miR-181a1b1-deficient
mice (n = 8–9; data represent two independent experiments).
(B) Cell-surface expression of CD25 on indicated populations of thymocytes fromWT andmiR-181a1b1-deficient mice, as revealed by flow cytometry (n = 5; data
are representative of at least four independent experiments).
(C) Absolute numbers, percentage, and representative flow-cytometry histogram of BrdU incorporation in double-positive (DP) thymocytes from WT and
miR-181a1b1-deficient mice after a single BrdU injection (n = 6; data are representative of three independent experiments).
(D) Percentage of annexin-V-negative WT and miR-181a1b1-deficient DP thymocytes at indicated time points of in vitro culture. A representative flow-cytometry
histogram is shown (n = 3; data are representative of three independent experiments).
(E) Relative decrease in DP thymocyte numbers and representative flow-cytometry plots in WT and miR-181a1b1-deficient mice injected with a single dose of
dexamethasone. Numbers shown are relative to PBS-injected control mice (n = 6–7, data represent two independent experiments).
(F) The ratio of miR-181a1b1-deficient (knockout, KO) to WT Tcra J gene-segment usage was obtained from the sequencing of Tcra chain mRNA in sorted
CD4+ thymocytes and was plotted as a function of relative distance along the Tcra locus. Each point represents the ratio obtained from the average values of
thymocytes independently sorted and sequenced from three WT and six miR-181a1b1-deficient mice. All error bars indicate the mean ± SEM. *p < 0.05,
**p < 0.01, and ***p < 0.001.
See also Figure S3.
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miR-181 Is an Essential Metabolic Rheostat In Vivoshowed that the absence of the miR-181a1b1 cluster leads to
decreased proliferation of developing NKT cells (Figure 6D).
The paucity of NKT cells in miR-181a1b1-deficient mice re-
veals that development of this lineage is uniquely sensitive to
PI3K-mediated metabolic dysregulation. We hypothesized that
reducing PTEN levels would allow rescue of NKT cell numbers
in the thymus ofmiR-181a1b1-deficient mice; however, because
Pten transcripts were upregulated by 65% in DP thymocytes990 Immunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc.(and visibly more at other stages), we reasoned that deletion of
only one Pten allele would be insufficient to rescue NKT develop-
ment. It must be noted that although PTEN is not absolutely
required for the generation of NKT cells, it is required for their
maturation from stage 2 to stage 3 of NKT cell ontogenesis.
Thus, we performed experiments in which one or both Pten
alleles were ablated by Cd4-Cre. As predicted, deletion of one
Pten allele resulted in a partial rescue of NKT development,
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Figure 4. miR-181a1b1-Deficient Mice Lack NKT Cells
(A) Relative frequency of the Va14-Ja18 NKT TCR usage in sorted CD4
+ thymocytes (designated Trav11.02–Traj18.01) fromWT andmiR-181a1b1-deficient mice,
as revealed by the sequencing of Tcra mRNA. Each point represents data from a single mouse.
(B) Absolute numbers and percentages of aGalCer-CD1d tetramer+TCRb+ NKT cells in the thymus, spleen, and liver of WT and miR-181a1b1-deficient mice.
(n = 7–8; data represent two independent experiments).
(C) Absolute numbers of aGalCer-CD1d tetramer+TCRb+ NKT cells in the thymus, spleen, and liver of WT (a1b1fl/fl) and miR-181a1b1fl/fl Cd4-Cre (a1b1fl/fl;Cd4-
Cre) mice (n = 7–8; data represent two independent experiments). All error bars indicate the mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S4.
Immunity
miR-181 Is an Essential Metabolic Rheostat In VivoPI3K signaling, and CD25 and CD62L expression (data not
shown), whereas deletion of both Pten alleles caused a complete
restoration of the number of developing NKT cells in the thymus
and completely restored appropriate expression of CD25 and
CD62L on developing thymocytes (Figures 6E–6G).
miR-181a1b1-Deficient Mice Display Multiple
Hematopoietic Defects
Becausemetabolic regulation hasglobal importance inbiological
processes requiring high rates of proliferation and because the
miR-181 family is ubiquitously expressed, we hypothesized thatmiR-181deletionwould affect additional PI3K-dependent events
in the hematopoietic system.We therefore assessed the effect of
ablation of the miR-181 clusters on peripheral T cell homeostatic
proliferation and early B cell development, both of which are
known to be regulated by PI3K signaling. PDK1-deficient
T cells, which lack PI3K signaling, are defective in their ability to
undergo homeostatic proliferation in a lymphopenic host (Finlay
et al., 2010). In concordance with this, miR-181a1b1-deficient
conventional ab T cells are significantly reduced (75%) in
peripheral tissues ofmixedbonemarrow (BM) chimeras reconsti-
tuted with miR-181a1b1-deficient and WT BM cells. (FiguresImmunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc. 991
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Figure 5. NKT Cell Developmental Defects in miR-181a1b1-Deficient Mice Are Cell Intrinsic and Independent of BCL-XL, BIM, and Tcra
Rearrangement
(A) Cell-surface expression of CD1d on DP thymocytes from WT and miR-181a1b1-deficient mice, as revealed by flow cytometry (n = 4). Representative flow-
cytometry histograms are shown.
(B) In brief, 0.5 3 106 WT and 0.5 3 106 miR-181a1b1-deficient bone marrow cells were injected into lethally irradiated hosts. Six weeks later, engraftment was
assessed on the basis of percentages of CD45.1 and CD45.2 cells in the spleen. Absolute numbers of WT (CD45.1) and miR-181a1b1-deficient (CD45.2)
aGalCer-CD1d tetramer+TCRb+ NKT cells in the thymus, spleen, and liver of transplanted mice (n = 8; data are representative of two independent experiments).
(C) Representative flow-cytometry dot plots from the spleen of bone-marrow-chimeric mice.
(D–F) Absolute numbers of aGalCer-CD1d tetramer+TCRb+ NKT cells in the thymus, spleen, and liver of (D) Tg-Bcl-xl- (a1b1WT;Tg-Bcl-xl) and Tg-Bcl-xl-miR-
181a1b1 (a1b1KO;Tg-Bcl-xl)-deficient mice (n = 7–8; data represent two independent experiments), (E) Bim/ (a1b1WT; BimKO) and Bim/ miR-181a1b1-
deficient (a1b1KO; BimKO) mice (n = 4–5), and (F) Tg-Va14-Ja18 (a1b1WT;Tg-Va14-Ja18) and Tg-Va14-Ja18-miR-181a1b1-deficient (a1b1KO; Tg-Va14-Ja18)
mice. (n = 4–5, data are representative of two independent experiments). All error bars indicate the mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S5.
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miR-181 Is an Essential Metabolic Rheostat In Vivo7A–7D). Identical results were obtained when mixed BM chi-
meras were reconstituted with miR-181a1b1fl/flCd4-Cre and
WT BM cells, excluding any potential contribution of differences
in thymic reconstitution (Figures S6A–S6C). In addition, to
exclude any potential influence of thymic output, we injected a
mixture (1:1) of CFSE-labeled, congenically marked WT and
miR-181a1b1-,miR-181a2b2-deficient naive T cells into lympho-
penic hosts (Rag1/ mice) and determined the relative engraft-
ment of T cells and their proliferation status after 10 days (Figures
7E–7H). In agreement with our previous results, we noted
reduced frequency, reduced total numbers, and reducedprolifer-
ative capacity of miR-181a1b1-, miR-181a2b2-deficient T cells
compared to WT T cells in peripheral lymphoid organs.
The miR-181a1b1 and miR-181a2b2 clusters are both highly
expressed during the early stages of B cell development (pro-
B cells and pre-B cells) (Kuchen et al., 2010). Recent evidence992 Immunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc.indicates that PI3K signaling is required for the development of
pro-B cells and the propagation of pre-B cells (Baracho et al.,
2011). Moreover, PI3K signaling promotes the retention of
FOXO1 in the nucleus, which drives Il7ra, Cd62l, and Rag
expression during early B cell development (Amin and Schlissel,
2008; Dengler et al., 2008). Therefore, we explored the potential
for B cell developmental defects in miR-181a1b1-, miR-
181a2b2-deficient mice. The frequency and total numbers of
B220+ cells in the bone marrow were decreased approximately
50% in miR-181a1b1-, miR-181a2b2-deficient mice as com-
pared to WT animals (Figure S6D). Furthermore, miR-181a1b1-,
miR-181a2b2-deficient mice showed a significant accumu-
lation of pro-B cells and a reduction of pre-B cells and immature
B cells, suggesting a defect in the transition from pro-B
cells to pre-B cells (Figures S6E–S6G). Finally, we noted
aberrant expression of CD62L on pro-B and pre-B cells in
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Figure 6. miR-181a1b1 Is Essential for Early Stages of NKT Cell Development
(A) Relative expression of miR-181a and miR-181b in sorted DP thymocyte and sorted NKT cells purified from the thymus of five pooled mice after tetramer
enrichment representing developmental stages 0–3, as determined by semiquantitative RT-PCR. Data are representative of two independent experiments.
Enriched aGalCer-CD1d tetramer+ NKT cells were subsequently sorted on the basis of the following markers. Stage 0: NK1.1; CD44; CD24+. Stage 1:
NK1.1; CD44; CD24. Stage 2: NK1.1; CD44+. Stage 3: NK1.1+; CD44+.
(B) Absolute numbers of aGalCer-enriched CD1d tetramer+ cells in the thymus, absolute numbers of stage 0 tetramer+ NKT cells in the thymus, and relative
numbers of stage 0 tetramer+ NKT cells out of the total number of CD1d tetramer+ NKT cells obtained after tetramer enrichment from the thymus of WT and miR-
181a1b1-deficient mice. Purifications were performed with thymuses pooled from multiple mice; each point represents 4–5 mice, and data are from three
independent experiments.
(legend continued on next page)
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Immunity
miR-181 Is an Essential Metabolic Rheostat In VivomiR-181a1b1-, miR-181a2b2-deficient mice (Figure S6H) as a
surrogate marker of reduced PI3K signaling. Thus, we conclude
that miR-181 is also required for normal lymphopenia-induced
T cell proliferation and for normal B cell development.
DISCUSSION
Metabolic regulation is emerging as a principal mechanism for
the active control of cellular function, growth, proliferation, and
survival. In the present study, we reveal that miR-181 is a non-
redundant rheostat of PTEN activity and cellular metabolism dur-
ing lymphoid development and homeostasis, highlighting the
miR-181 family as one of the most important miRNA families
described to date.
Through the regulation of PI3K signaling, the miR-181a1b1
cluster promotes a cellular anabolic reprogramming that is
necessary to sustain the biosynthetic demands encountered
during development. The physiological importance of this finding
is highlighted by the observation that miR-181a1b1 cluster dele-
tion results in a complete absence of NKT cells in the thymus and
the periphery; indeed, this is a unique example where deletion of
a single miRNA cluster causes the loss of an entire cell lineage. In
addition, miR-181-deficient mice show severe defects in T cell
development and homeostasis and defects during early B cell
development, as well as reduced organism size, revealing that
miR-181-mediated metabolic regulation has global physiolog-
ical importance.
Interestingly, NKT cell development appears to be particularly
sensitive to alterations inmetabolic fitness, which likely reflects a
number of aspects unique to NKT cell ontogenesis. First, devel-
oping thymocytes must successfully express a functional NKT
TCR; this necessitates use of one of the most distal Tcra J
gene segments and therefore requires extended thymocyte sur-
vival (D’Cruz et al., 2010). Second, after diverging from the T cell
lineage, developing NKT cells must undergo a rapid and vast
burst of proliferation. Third, expression of the key metabolic
regulator MYC is specifically required during early NKT cell
development (Dose et al., 2009; Mycko et al., 2009). Each of
these three independent biological events depends upon PI3K
signaling to provide adequate metabolic fitness necessary to
support prolonged thymocyte survival and foster early NKT cell
proliferation. Therefore, consistent with the data presented here-
in, the paucity of NKT cells in miR-181a1b1-deficient mice most
likely results from the cumulative effect of impaired PI3K
signaling during multiple stages of NKT development.
Although miRNAs have previously been shown to target
different components of the PI3K-PTEN axis, the physiological(C) Relative frequency of NKT stages 1–3 in aGalCer-CD1d tetramer+, TCRb+ NKT
Representative plots are shown.
(D) Representative flow-cytometry histograms showing BrdU incorporation in
(a1b1WT;Tg-Va14-Ja18) and Tg-Va14-Ja18-miR-181a1b1-deficient (a1b1KO;Tg
independent experiments).
(E) Absolute number and relative frequency of aGalCer-CD1d tetramer+, TCRb+
(a1b1fl/fl;Pten+/+;Cd4-Cre) and miR-181a1b1fl/flPtenfl/flCd4-Cre (a1b1fl/fl;Ptenfl/fl;C
(F) Representative flow-cytometry plots from (E).
(G) Cell-surface expression of CD62L and CD25 on developing thymocytes from
and miR-181a1b1fl/flPtenfl/flCd4-Cre (a1b1fl/fl;Ptenfl/fl;Cd4-Cre) mice (data are fr
*p < 0.05, **p < 0.01, and ***p < 0.001.
994 Immunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc.relevance of the majority of these interactions remains to be es-
tablished, especially in light of the general lack of gross pheno-
types in miRNA-knockout mice (Ebert and Sharp, 2012; Huse
et al., 2009; Inui et al., 2010; Ma et al., 2011; Mendell and Olson,
2012; Olive et al., 2009; Park et al., 2010; Patrick et al., 2010;
Small et al., 2010; Ventura et al., 2008). In contrast, the robust
metabolic phenotypes observed upon deletion ofmiR-181 family
members at the organism and cellular level, along with the ability
of a genetic reduction of PTEN levels to rescue developmental
abnormalities, confirms the function of this miRNA family in
metabolic regulation. Thus, miR-181 represents an example of
a miRNA family that functions as a bona fide cellular metabolic
rheostat during development in vivo.
Finally, whereas PTEN downregulation is a hallmark of many
cancers and obesity, overexpression of miR-181 is considered
a signature of a wide variety of solid tumors and leukemias (Calin
et al., 2005; Carracedo et al., 2011; Jones et al., 2012). We there-
fore propose that dysregulation of the miR-181-PTEN axis might
drive development of cancer and metabolic syndrome.
EXPERIMENTAL PROCEDURES
NKT Purification
Single-cell suspensions from thymus were incubated with phycoerthryin-
conjugated aGalCer-loaded CD1d tetramers. NKT cells were then isolated
by positive selection on an LS column according to the manufacturer’s
instructions.
CXCL12 Stimulation and Phosphoflow
Freshly isolated thymocytes were resuspended at 1 3 107 cells/ml in
Dulbecco’s modified Eagle’s medium (DMEM) with 0.1% BSA. Cells were res-
ted at 37C for 20min before the addition of 10 nMCXCL12 (Peprotech) for the
indicated time points. Cells were then fixed by the addition of an equal volume
of 4% PFA and incubated at 37C for an additional 15 min. Fixed cells were
washed twice with fluorescence-activated cell sorting (FACS) buffer, permea-
bilized in ice-cold 90%methanol, and stored at20C for 1 hr. Before staining,
fixed cells were washed three times in FACS buffer. Staining was performed at
room temperature for 1 hr. Stained cells were washed twice and subsequently
stained with an Alexa Fluor 488 conjugated anti-rabbit antibody at room
temperature for 30 min. After three washes, cells were analyzed by flow
cytometry. The following phospho-specific antibodies from Cell Signaling
were used: Phospho-AKT (Ser473) (193H12) and Phospho-p44/42 MAPK
(ERK1/2) (Thr202/Tyr204) (D13.14.4E).
TCR Stimulation
Thymocytes were resuspended at 5 3 106 cells/ml in RPMI with 10% fetal
bovine serum (FBS) and rested at 37C for 20 min before being spun onto
tissue culture plates precoated with anti-CD3 (10 mg/ml) and anti-CD28
(50 mg/ml). At indicated time points cells were removed with a cell scraper
and immediately transferred onto ice, centrifuged, and resuspended in ice-
cold lysis buffer (Cell Signaling) containing a protease inhibitor cocktail (Roche)cells (n = 4, data are representative of at least four independent experiments).
aGalCer-CD1d tetramer+, TCRb+ NKT cells (stage 0–3) from Tg-Va14-Ja18
-Va14-Ja18) mice after a single BrdU injection (data are representative of two
NKT cells in the thymus of miR-181a1b1fl/fl (a1b1fl/fl), miR-181a1b1fl/flCd4-Cre
d4-Cre) mice (data are from two independent experiments).
miR-181a1b1fl/fl (a1b1fl/fl), miR-181a1b1fl/flCd4-Cre (a1b1fl/fl;Pten+/+;Cd4-Cre)
om two independent experiments). All error bars indicate the mean ± SEM.
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Figure 7. Aberrant Lymphopenia-Induced T Cell Proliferation in the Absence of miR-181a1b1 and miR-181a2b2
(A–D) Lymphopenia-induced proliferation of WT and miR-181a1b1-deficient cells. (A and B) In brief, 0.5 3 106 WT and 0.5 3 106 miR-181a1b1-deficient bone
marrow cells were injected into lethally irradiated hosts. Six weeks later, we assessed engraftment by determining the percentages of CD45.1 and CD45.2 cells in
the thymus and spleen. (C and D) Absolute numbers and percentages of WT (CD45.1) and miR-181a1b1-deficient (CD45.2) B cells (B200+) and T cells (TCRb+) in
the spleen were determined by flow cytometry. (n = 8; data are representative of two independent experiments).
(E–H) Analysis of lymphopenia-induced proliferation. Sorted naive CD4+ T cells fromWT (CD45.1) and miR-181a1b1-miR-181a2b2-deficient (CD45.2) mice were
labeled with CFSE and injected into Rag/mice in equal proportions. The relative proportion of cells of each genotype in the injected mixture was assessed by
flow cytometry. Ten days after injection, spleen and lymph nodes were harvested from transplanted mice, and (E) the absolute number and (F) percentage of
injected cells was quantified by flow cytometry. (G) and (H) The proliferation of injected cells was assessed by CFSE dilution. (n = 6; data are representative of two
independent experiments). All error bars indicate the mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S6.
Immunity
miR-181 Is an Essential Metabolic Rheostat In Vivoand a phosphatase inhibitor (Thermo Scientific). Protein lysates were analyzed
by immunoblot.
Thymocyte Survival Culture
Thymocytes were cultured at a concentration of 13 106 to 33 106 cells/ml in
DMEM supplemented with 10% FBS and 1% penicillin-streptomycin-L-gluta-mine (PSG). Cells were harvested at indicated time points, and survival was
assessed by Annexin V staining.
Dexamethasone Culture
Thymocyteswere cultured at a concentration of 33 106 cells/ml in DMEMsup-
plemented with 10% FBS and 1% PSG. Cells were incubated with theImmunity 38, 984–997, May 23, 2013 ª2013 Elsevier Inc. 995
Immunity
miR-181 Is an Essential Metabolic Rheostat In Vivoindicated concentrations of dexamethasone for 24 hr before survival was
assessed by annexin V staining.
Dexamethasone Injection
Age-, weight-, and sex-matched mice were injected with a single intraperito-
neal dose of dexamethasone (150 mg/mouse). Twenty hours later, mice were
euthanized, and thymocytes were analyzed by annexin V and PI staining.
BrdU Incorporation
Mice were injected with a single intraperitoneal dose of BrdU (1mg) and were
sacrificed 24 hr later, and single-cell suspensions were obtained from thymus.
BrdU flow kit (BDbiosciences) was used to detect BrdU as directed by the
manufacturer’s instructions.
Seahorse Metabolic Studies
Analysis of the oxygen consumption rate (OCR) and extracellular acidification
rate (ECAR) of thymocytes was performed with a Seahorse XF96 Extracellular
Flux Analyzer instrument. In brief, WT or knockout thymocytes were seeded at
least in triplicate at a density of 1 3 106/well on poly-D-lysine-coated plates,
and the OCR and ECAR were measured in real time.
Glucose Uptake, Mitosox, and Mitochondrial Mass
For analysis of glucose uptake, mitochondrial mass, and mitochondrial reac-
tive oxygen species, thymocytes were pulsed with either 2-NBDG, mitotracker
green, and mitosox red dyes (Invitrogen) for 10 min at 37C in RPMI containing
1% FCS or glucose-free RPMI containing 1% FCS (glucose uptake assay,
specifically). Cells were then washed with FACS buffer and stained as usual
for flow cytometry.
Statistical Analysis
Unless otherwise stated, we performed statistical analysis by using a one-way
ANOVAwith a Bonferroni multiple-comparison post test and a Student’s t test.
We considered p < 0.05 to be statistically significant.
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